siglec-9 checkpoint inhibitor (Innate Pharma)

N/A

Report date: 2025/03/20 09:48:18

Base Information

Drug Namesiglec-9 checkpoint inhibitor (Innate Pharma)
Drug Alias Nameanti-siglec-9 antibodies (Innate Pharma)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionSialic acid-binding Ig-like lectin 9 inhibitors
TargetsSialic acid-binding Ig-like lectin 9
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInnate Pharma SA
China Registration ClassN/A

Develop Information

Active CompaniesInnate Pharma SA
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A